1. Home
  2. WAT vs FE Comparison

WAT vs FE Comparison

Compare WAT & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • FE
  • Stock Information
  • Founded
  • WAT 1958
  • FE 1996
  • Country
  • WAT United States
  • FE United States
  • Employees
  • WAT N/A
  • FE N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • FE Electric Utilities: Central
  • Sector
  • WAT Industrials
  • FE Utilities
  • Exchange
  • WAT Nasdaq
  • FE Nasdaq
  • Market Cap
  • WAT 20.8B
  • FE N/A
  • IPO Year
  • WAT 1995
  • FE N/A
  • Fundamental
  • Price
  • WAT $304.39
  • FE $40.43
  • Analyst Decision
  • WAT Buy
  • FE Buy
  • Analyst Count
  • WAT 15
  • FE 15
  • Target Price
  • WAT $385.27
  • FE $46.15
  • AVG Volume (30 Days)
  • WAT 574.0K
  • FE 4.3M
  • Earning Date
  • WAT 08-04-2025
  • FE 07-30-2025
  • Dividend Yield
  • WAT N/A
  • FE 4.40%
  • EPS Growth
  • WAT 8.23
  • FE 1.45
  • EPS
  • WAT 11.02
  • FE 1.88
  • Revenue
  • WAT $2,983,253,000.00
  • FE $13,764,000,000.00
  • Revenue This Year
  • WAT $6.11
  • FE $9.20
  • Revenue Next Year
  • WAT $6.44
  • FE $3.82
  • P/E Ratio
  • WAT $27.62
  • FE $21.50
  • Revenue Growth
  • WAT 2.57
  • FE 8.03
  • 52 Week Low
  • WAT $297.14
  • FE $37.58
  • 52 Week High
  • WAT $423.56
  • FE $44.97
  • Technical
  • Relative Strength Index (RSI)
  • WAT 26.81
  • FE 50.10
  • Support Level
  • WAT $343.83
  • FE $39.34
  • Resistance Level
  • WAT $360.00
  • FE $40.59
  • Average True Range (ATR)
  • WAT 10.88
  • FE 0.53
  • MACD
  • WAT -2.68
  • FE 0.11
  • Stochastic Oscillator
  • WAT 3.01
  • FE 76.08

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.

Share on Social Networks: